Metabolic Syndrome Is Associated With Altered mRNA and miRNA Content in Human Circulating Extracellular Vesicles.
Metabolic Syndrome Is Associated With Altered mRNA and miRNA Content in Human Circulating Extracellular Vesicles.
复制标题
DOI:
10.3389/fendo.2021.687586
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Lerman LO
中科院分区:
文献类型:
--
作者:
Li Y;Meng Y;Zhu X;Van Wijnen A;Eirin A;Lerman LO
As mediators of intercellular communication, circulating extracellular vehicles (EVs) can modulate tissue and cellular pathways by altering transcription profiles in recipient cells, and their content may reflect the status of their parent cells. However, whether their cargo is altered in the metabolic syndrome (Mets) remains unclear. We hypothesized that MetS altered mRNAs and miRNAs packed within circulating-EVs. EVs were collected from plasma of patients with MetS or age-matched Lean controls (n=4 each). RNA sequencing was performed to identify dysregulated mRNAs and miRNAs, and analyze genes targeted by miRNAs, top pathways, and diseases associated with MetS-EVs. MetS patients showed elevated body weight, blood pressure, glucose, insulin, and liver injury markers levels. 1,446 mRNAs were downregulated and 32 upregulated in MetS- compared to Lean-EVs, whereas 40 miRNAs were selectively enriched and 10 downregulated in MetS-EVs. MetS upregulated in EVs genes involved in apoptosis, mitochondrial regulation, transport, and lipoproteins, but downregulated vessel and heart development, protein complex biogenesis, and angiogenesis. MetS also upregulated miRNAs targeting genes implicated in cellular processes, including oxidation–reduction, and downregulated miRNAs capable of modulating catalytic activity, as well as heart, blood vessel, and skeletal development, transcriptional regulation, apoptosis, and cell cycle. Our study, thus, indicates that human subjects with MetS show modified cargo of circulating EVs, which in turn may modulate several critical cellular functions and fate. These EVs may reflect the anomalous status of their parent cells, and potentially serve as important regulators, biomarkers, and targets in the progression and treatment of MetS.
登录
查看更多内容
影响因子:
64.5
作者:
Crewe C;Joffin N;Rutkowski JM;Kim M;Zhang F;Towler DA;Gordillo R;Scherer PE
通讯作者:
Scherer PE
影响因子:
6.1
作者:
Singh N;Lawana V;Luo J;Phong P;Abdalla A;Palanisamy B;Rokad D;Sarkar S;Jin H;Anantharam V;Kanthasamy AG;Kanthasamy A
通讯作者:
Kanthasamy A
影响因子:
2.7
作者:
Eirin, Alfonso;Hedayat, Ahmad F.;Lerman, Lilach O.
通讯作者:
Lerman, Lilach O.
影响因子:
3.8
作者:
Ramzan, F.;D'Souza, R. F.;Cameron-Smith, D.
通讯作者:
Cameron-Smith, D.
影响因子:
4.6
作者:
Eirin A;Zhu XY;Puranik AS;Woollard JR;Tang H;Dasari S;Lerman A;van Wijnen AJ;Lerman LO
通讯作者:
Lerman LO